Co-expression of CD44 and CD24 is frequently observed in basal/epithelial breast cancer cells [28] and CD44+/CD24+ cells have shown to be more invasive and tumorigenic than CD44+/CD24neg cells and possess stemness characteristics of self-renewal and differentiation in multiple cancer types [29, 30]. The gene discussed is CD24; the disease is breast cancer.